Abstract
Abstract
Background
COVID-19 has been linked to a range of cardiovascular complications. This study investigates the potential role of persistent inflammatory responses in the development of post-COVID cardiomyopathy.
Methods
A cohort of COVID-19-recovered patients was assessed for signs of cardiomyopathy using echocardiography, blood biomarkers, and inflammation markers. Patient data were analyzed to determine correlations between inflammatory responses and cardiomyopathy indicators.
Results
The study found a significant association between elevated levels of inflammatory markers and reduced ejection fraction, a key indicator of cardiomyopathy. Patients with persistent high inflammatory responses showed a higher prevalence of cardiomyopathy symptoms.
Conclusion
Persistent inflammatory responses in post-COVID patients appear to be a contributing factor to the development of cardiomyopathy. This finding underscores the importance of monitoring inflammation in COVID-19 survivors to identify those at risk for cardiac complications.
Publisher
Research Square Platform LLC